Rayment et al., 1995 - Google Patents
Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.Rayment et al., 1995
View PDF- Document ID
- 384425135050519772
- Author
- Rayment I
- Holden H
- Sellers J
- Fananapazir L
- Epstein N
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
In 10-30% of hypertrophic cardiomyopathy kindreds, the disease is caused by> 29 missense mutations in the cardiac beta-myosin heavy chain (MYH7) gene. The amino acid sequence similarity between chicken skeletal muscle and human beta-cardiac myosin and the three …
- 230000035772 mutation 0 title abstract description 64
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rayment et al. | Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. | |
Cuda et al. | The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy | |
Harrison et al. | Identification of the t complex–encoded cytoplasmic dynein light chain Tctex1 in inner arm I1 supports the involvement of flagellar dyneins in meiotic drive | |
Zahler et al. | Distinct functions of SR proteins in alternative pre-mRNA splicing | |
Andres et al. | cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein | |
Poetter et al. | Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle | |
Stewart et al. | Adaptive evolution in the stomach lysozymes of foregut fermenters | |
Ren et al. | The crystal structure of seleno-glutathione peroxidase from human plasma at 2.9 Å resolution | |
Lincoln et al. | Adenosine 3′: 5′-cyclic monophosphate-and guanosine 3′: 5′-cyclic monophosphate-dependent protein kinases: possible homologous proteins | |
Whittaker et al. | Duodenal iron proteins in idiopathic hemochromatosis. | |
Takeda et al. | Nuclear genes coding the yeast mitochondrial adenosine triphosphatase complex. Primary sequence analysis of ATP2 encoding the F1-ATPase beta-subunit precursor. | |
Charlab et al. | The salivary adenosine deaminase from the sand fly Lutzomyia longipalpis | |
Daw et al. | Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes | |
Sweeney | Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. | |
GB9923306D0 (en) | Diagnostic and therapeutic epitope, and transgenic plant | |
JPH10327880A (en) | Human sodium-dependent phosphate carrier (ipt-1) | |
Shaw et al. | The crystal structure of lysin, a fertilization protein | |
Glele‐Kakai et al. | Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin | |
Gupta et al. | Emerging functions of actins and actin binding proteins in trypanosomatids | |
Penniston et al. | Plasma membrane Ca2+ pump: recent developments | |
King et al. | Axonemal dyneins: genetics, structure, and motor activity | |
Jayasekera et al. | Evaluation of functionally important amino acids in L-aspartate ammonia-lyase from Escherichia coli | |
Mauch et al. | Baculovirus-mediated expression of human 65 kDa and 67 kDa glutamic acid decarboxylases in SF9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus | |
Epstein | The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains | |
Sabina et al. | Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms |